RxDoctor Payments Data

Stacey Schwartz, DPM

Podiatrist · Farmington Hills, MINPI 1487649562

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,053 of the $5,572 with a category attached, or 72.7%. 36 manufacturers reported payments, led by Paragon 28, Inc. at 32.5% of the total.

$5,572in general payments, 2019–2025

Across 89 payments — averaging $62.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$2K
  • Stryker$1K
  • Integra Lifesciences Corporation$233
  • Smith+Nephew$206
  • Cardiovascular Systems Inc.$173
  • Aroa Biosurgery Incorporated$170
  • plus $2K from 30 others

What the payments were for

  • Travel & lodging$1,51927%
  • Food & beverage$4,05373%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,572 in reported general payments places this provider in the 80th percentile of 302 podiatrist providers in Michigan.

See all podiatrist providers in Michigan

Medicare billing

Part B allowed, 2024
$134,880
Medicare patients
323
Services billed
1,580

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nystatin63$1,478
Terbinafine Hcl92$1,067
Febuxostat14$900
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip33$855
Gentamicin Sulfate16$622
Ketoconazole15$397
Ciclopirox20$299
Gabapentin25$249
Cephalexin49$194
Allopurinol19$192
Doxycycline Hyclate27$165
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen24$91
Methylprednisolone16$84
Meloxicam27$72

Paid to pharmacies, not to this prescriber.

Other podiatrist in Farmington Hills

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →